234 related articles for article (PubMed ID: 2624663)
1. Interferon alpha-2a to control thrombocytosis in chronic myelogenous leukemia and essential thrombocythemia.
Jootar S
Asian Pac J Allergy Immunol; 1989 Dec; 7(2):103-5. PubMed ID: 2624663
[TBL] [Abstract][Full Text] [Related]
2. [Therapy of thrombocytosis in myeloproliferative syndromes using recombinant interferon-alpha-2a].
Tichelli A; Gratwohl A; Delacrétaz F; Dazzi H; Stebler C; Wernli M; Holdener EE; Nissen C; Speck B
Schweiz Med Wochenschr; 1989 Sep; 119(39):1347-52. PubMed ID: 2799342
[TBL] [Abstract][Full Text] [Related]
3. Treatment of thrombocytosis in myeloproliferative disorders with interferon alpha-2a.
Tichelli A; Gratwohl A; Berger C; Lori A; Würsch A; Dieterle A; Thomssen C; Nissen C; Holdener E; Speck B
Blut; 1989 Jan; 58(1):15-9. PubMed ID: 2644994
[TBL] [Abstract][Full Text] [Related]
4. [Thrombocytosis in chronic myelogenous leukemia (CML) controlled by interferon alpha (IFN-alpha)].
Koike G; Otsuka T; Shibuya T; Niho Y
Rinsho Ketsueki; 1989 Mar; 30(3):400-3. PubMed ID: 2769964
[TBL] [Abstract][Full Text] [Related]
5. Human leukocyte interferon to control thrombocytosis in chronic myelogenous leukemia.
Talpaz M; Mavligit G; Keating M; Walters RS; Gutterman JU
Ann Intern Med; 1983 Dec; 99(6):789-92. PubMed ID: 6580836
[TBL] [Abstract][Full Text] [Related]
6. Recombinant interferon-alpha therapy of Philadelphia chromosome-negative myeloproliferative disorders with thrombocytosis.
Talpaz M; Kurzrock R; Kantarjian H; O'Brien S; Gutterman JU
Am J Med; 1989 May; 86(5):554-8. PubMed ID: 2712063
[TBL] [Abstract][Full Text] [Related]
7. [Chronic myelogenous leukemia with marked thrombocytosis].
Hasegawa T; Hino M; Yamane T; Ota K; Takubo T; Kitagawa S; Tatsumi N
Rinsho Ketsueki; 2001 Mar; 42(3):199-203. PubMed ID: 11345782
[TBL] [Abstract][Full Text] [Related]
8. A phase I/II study of recombinant interferon alpha 2a and hydroxyurea for chronic myelocytic leukemia.
Anger B; Porzsolt F; Leichtle R; Heinze B; Bartram C; Heimpel H
Blut; 1989 Jun; 58(6):275-8. PubMed ID: 2736308
[TBL] [Abstract][Full Text] [Related]
9. [Therapy with interferon (recombinant IFN-alpha-2C) in myeloproliferative diseases with severe thrombocytoses].
Linkesch W; Gisslinger H; Ludwig H; Flener R; Sinzinger H
Acta Med Austriaca; 1985; 12(5):123-7. PubMed ID: 3914173
[TBL] [Abstract][Full Text] [Related]
10. alpha Interferon treatment of essential thrombocythaemia and other myeloproliferative disorders with excessive thrombocytosis.
Yataganas X; Meletis J; Plata E; Viniou N; Deligiannis F; Tsekoura C; Voscaridou E; Boussiotis V; Rombos J; Vayopoulos G
Eur J Cancer; 1991; 27 Suppl 4():S69-71. PubMed ID: 1799484
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of essential thrombocythemia in a pregnancy with recombinant interferon-alpha 2a.
Milano V; Gabrielli S; Rizzo N; Vianelli N; Gugliotta L; Orsini LF; Baravelli S; Pilu GL; Bovicelli L
J Matern Fetal Med; 1996; 5(2):74-8. PubMed ID: 8796772
[TBL] [Abstract][Full Text] [Related]
12. Combined therapy interferon and chemotherapy in chronic myelogenous leukemia.
Guilhot F; Dreyfus B; Desmarest MC; Giraud C; Huret JL; Brizard A; Tanzer J
Nouv Rev Fr Hematol (1978); 1989; 31(2):171-3. PubMed ID: 2771633
[TBL] [Abstract][Full Text] [Related]
13. [Use of interferon in patients with hairy cell leukemia and myeloproliferative disorders].
Skotnicki AB; Wolska-Smoleń T
Acta Haematol Pol; 1994; 25(2 Suppl 1):124-35. PubMed ID: 8067197
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic plateletpheresis in a case of symptomatic thrombocytosis in chronic myeloid leukemia.
Thakral B; Saluja K; Malhotra P; Sharma RR; Marwaha N; Varma S
Ther Apher Dial; 2004 Dec; 8(6):497-9. PubMed ID: 15663550
[TBL] [Abstract][Full Text] [Related]
15. Use of quantitative polymerase chain reaction to monitor residual disease in chronic myelogenous leukemia during treatment with interferon.
Lion T; Gaiger A; Henn T; Hörth E; Haas OA; Geissler K; Gadner H
Leukemia; 1995 Aug; 9(8):1353-60. PubMed ID: 7643624
[TBL] [Abstract][Full Text] [Related]
16. Activity of alpha-interferons in chronic myelogenous leukaemia.
Talpaz M
Br J Clin Pract Suppl; 1988 Mar; 62():13-5. PubMed ID: 3145008
[No Abstract] [Full Text] [Related]
17. Leukocyte interferon in the treatment of chronic myelogenous leukemia in second chronic phase.
Wahlin A; Holm J; Engman K
Acta Oncol; 1991; 30(5):611-5. PubMed ID: 1892679
[TBL] [Abstract][Full Text] [Related]
18. [Isolated thrombocytosis in chronic myeloid leukemia without significant leukocytosis].
Okano M; Sugimoto Y; Ohishi K; Miyazaki K; Monma F; Katayama N
Rinsho Ketsueki; 2017; 58(7):766-771. PubMed ID: 28781272
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune mediated thrombocytopenia associated with the use of interferon-alpha in chronic myeloid leukemia.
Zuffa E; Vianelli N; Martinelli G; Tazzari P; Cavo M; Tura S
Haematologica; 1996; 81(6):533-5. PubMed ID: 9009441
[TBL] [Abstract][Full Text] [Related]
20. Alpha-2a interferon therapy and antibody formation in patients with essential thrombocythemia and polycythemia vera with thrombocytosis.
Törnebohm-Roche E; Merup M; Lockner D; Paul C
Am J Hematol; 1995 Mar; 48(3):163-7. PubMed ID: 7864024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
